previous compound ID: 2491 next compound
InChIKey: WOFMFGQZHJDGCX-ZULDAHANSA-N
SMILES: C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"R Robert" "B Kus" "GW Carlile" "J Goepp" "SD Macknight" "E Matthes" "DY Thomas" "J Liao" "JW Hanrahan" "D Rotin"

chemical graph of compound 2491





CID is 441336
synonyms found at PubChem are:
mometasone furoate, 83919-23-7, Nasonex, Ecural, Elomet, Asmanex, MOMETASONE FUROATE MONOHYDRATE, mometasone 17-furoate, Danitin, UNII-04201GDN4R, Asmanex Twisthaler, CHEMBL1161, Elocone, Flumeta, Nosorex, Rimelon, CHEBI:47564, 04201GDN4R, Sch 32088, DSSTox_CID_3333, DSSTox_RID_76981, DSSTox_GSID_23333, [(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate, 9,21-dichloro-11beta-hydroxy-16alpha-methyl-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate, C27H30Cl2O6, Sch-32088, Monovo, Ovixan, Asmanex HFA, BRN 4340538, (8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate, (9beta,10alpha,11alpha,14beta,16alpha,17alpha)-9,21-dichloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate, Sinuva, 9,21-Dichloro-11beta,17-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 17-(2-furoate), NCGC00016950-01, Prestwick_924, Mometasone furoate [USAN:USP:JAN], CAS-83919-23-7, LAS 41002, AC1L9AZS, Prestwick0_000572, Prestwick1_000572, Prestwick2_000572, Prestwick3_000572, mometasone furancarboxylate, SCHEMBL4568, BSPBio_000384, Mometasone 17-(2-furoate), MLS002153879, Mometasone Furoate Impurity G, SPBio_002603, Mometasone furoate (JAN/USP), BPBio1_000424, DTXSID4023333, KS-00000SPL, MolPort-003-849-257, WOFMFGQZHJDGCX-ZULDAHANSA-N, HMS1569D06, HMS2096D06, HMS2235I14, HMS3713D06, Pregna-1,4-diene-3,20-dione, 9,21-dichloro-17-((2-furanylcarbonyl)oxy)-11-hydroxy-16-methyl-, (11beta,16alpha)-, ZINC3938677, Tox21_110705, AC-941, BDBM50148733, NSC746171, s1987, Mometasone furoate, >=98% (HPLC), AKOS015994732, Tox21_110705_1, CCG-220572, CS-2389, KS-1275, NSC-746171, NCGC00179578-01, NCGC00179578-03, NCGC00179578-04, AN-15438, BC228151, HY-13693, SMR001233233, AB2000407, TL8005500, M2354, ST24048112, C07817, D00690, 919M237, A840685, SR-01000841209, Q-101380, SR-01000841209-2, BRD-K60640630-001-03-7, BRD-K60640630-001-11-0, Mometasone furoate, European Pharmacopoeia (EP) Reference Standard, Mometasone furoate, United States Pharmacopeia (USP) Reference Standard, 11?,16?)-9,21-Dichloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl 2-furoate, Mometasone Furoate, Pharmaceutical Secondary Standard; Certified Reference Material, (11beta,16alpha)-9,21-dichloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate, (11beta,16alpha)-9,21-Dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methylpregna-1,4-diene-3,20-dione, [(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloranyl-17-(2-chloranylethanoyl)-10,13,16-trimethyl-11-oxidanyl-3-oxidanylidene-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate, 2-furancarboxylic acid [(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloro-1-oxoethyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] ester, Pregna-1,20-dione, 9,21-dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methyl-, (11.beta.,16.alpha.)-